Analyzing the options chain and the chart patterns of AUPH Aurinia Pharmaceuticals prior to the earnings report this week,
I would consider purchasing the 7usd strike price Calls with
an expiration date of 2024-3-15,
for a premium of approximately $1.50.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
BULLISH WEDGE
Been brewing since FDA approval of Voclosporin. Lots of reasons to speculate a buyout or possible merger with recent voluntary delisting from the TSX and remaining on NYSE. Excellent setup to be a cash cow. Target Price of $35 be EOY playing Oct Calls. PFE and MRNA are LOADED with cash and you know they're sniffing out opportunities and would love...
